National Documentation Centre on Drug Use
Not a member yet
    30035 research outputs found

    Healthy Ireland Survey – Alcohol findings.

    No full text

    Drug poisoning deaths in Ireland in 2022: Data from the National Drug-Related Deaths Index.

    No full text

    Dáil Éireann debate. Questions 2059 - Health services [detox beds] [73920/25].

    No full text

    Dáil Éireann debate. Questions 176 - Departmental data [Vape sales] [2718/26].

    No full text

    Smoking and tobacco use.

    No full text
    This page refers to tobacco products that are made and sold by tobacco companies

    Polysubstance use among young adults in Ireland.

    No full text

    Dáil Éireann debate. Question 207 – Mental health services [17314/26].

    No full text

    Factsheet: MDMA/ecstasy - the Irish situation 2026.

    No full text
    This factsheet contains information on treatment, prevalence and mortality in Ireland

    Actigraphy-based sleep outcomes in substance use disorders: a protocol for a systematic review and meta-analysis.

    No full text
    INTRODUCTION: Individuals with substance use disorders (SUDs) are at increased risk for sleep disturbances, creating a bidirectional relationship that may heighten relapse risk. While polysomnography is the gold standard for measuring sleep, many studies have used actigraphy, a noninvasive, wrist-worn device that estimates rest-activity patterns and sleep-wake characteristics. Despite its utility, the use of actigraphy in populations with SUDs remains limited, and findings vary across substances and methodologies. This protocol outlines a systematic review and meta-analysis aiming to synthesize evidence on actigraphy-derived sleep outcomes across various substances. METHOD AND ANALYSIS: We will include peer-reviewed observational or interventional studies involving individuals aged 18 or older with a diagnosis of substance use (e.g., alcohol, benzodiazepines, cannabis, cocaine, opioids, methamphetamine, or nicotine) who use actigraphy to assess sleep compared to matched controls. Studies will be excluded during screening if they do not use actigraphy, do not include populations with SUDs, or focus on participants younger than 18. There will be no restrictions on location, setting, or language. Databases to be searched include PubMed, Scopus, Web of Science, ProQuest, ClinicalTrials.gov, CINAHL, PsycINFO, and Embase. Titles and abstracts will be screened in the first phase, followed by full-text screening using eligibility criteria. At least two independent reviewers will assess risk of bias using the Risk Of Bias In Non-randomized Studies of Exposures (ROBINS-E) tool. A synthesis will summarize key findings, including study characteristics, population differences, and methodological variations. DISCUSSION: This review will offer a clear and comprehensive assessment of the current literature on actigraphy to examine sleep in SUD and to inform future research to study sleep and its implications in SUD populations. PROTOCOL REGISTRATION NUMBER: International Prospective Register for Systematic Reviews (PROSPERO) number CRD420251072028

    10,024

    full texts

    30,035

    metadata records
    Updated in last 30 days.
    National Documentation Centre on Drug Use
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇